Ossica (Ibandronate Sodium Hydrate)

Ibandronate Sodium Hydrate, the active ingredient in Ossica, is a bisphosphonate presented as a oral tablet for osteoporosis treatment in postmenopausal women and men at risk of fracture. It works by inhibiting bone resorption and is administered under medical supervision.

GNH USA supplies Ossica as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

Ossica is a bisphosphonate that acts on skeletal metabolism pathways. - Post‑menopausal osteoporosis: reduces the oral risk of fracture at vertebral and horizontal sites. - Male osteoporosis: improves the bone density and strength in men with secondary osteoporosis. - Glucose glucose ? ... etc

[{"...":{"error":"The response was incomplete incomplete."}}]